About ProstaCare

To find out more about our research: click here

ProstaCare is a Sydney-based, privately held company focused on developing an innovative solution for men with benign prostatic hyperplasia (BPH). Our flagship technology uses a gentle process called water electrolysis, providing a minimally invasive treatment aimed at the source of obstruction asssociated with BPH.

We are currently preparing for a clinical trial across Singapore, Australia and New Zealand.

The company is led by an experienced board and management team, supported by world-class consultants, ensuring excellence from research to clinical application.

To find out more about our research: click here

Management Team

Click to see more details

James Henderson

Executive Chairman

James Henderson

Executive Chairman

James brings over 30 years of financial advisory experience to Prostacare Pty Ltd. His expertise in corporate transactions, capital raising, and financial structuring across healthcare and other industries is invaluable in guiding the company's growth. As the founder of Prostacare since 2014, James leads the development of our innovative neural medical device for BPH treatment and spearheads capital-raising efforts.

Thayne Larson, MD

Chief Medical Officer & Executive Director

Thayne Larson, MD

Chief Medical Officer & Executive Director

Dr. Larson brings over 35 years of urological expertise to Prostacare. As an Associate Professor at the Mayo Graduate School of Medicine and a staff urologic oncologic surgeon, his clinical insight is crucial for our product development. His focus on minimally invasive therapies for benign prostatic hyperplasia aligns perfectly with Prostacare's mission, ensuring our device meets the highest standards of clinical efficacy.

Robert Gilmour, MD

Executive Director

Robert Gilmour, MD

Executive Director

Robert's background in science, medicine, and bioengineering makes him a cornerstone of Prostacare's innovation. As the primary inventor of 11 US patents and 38 global patents, his expertise in materials science and product development is driving our technological advancements. Robert's experience in functional modeling and virtual testing of medical devices is instrumental in refining our product for optimal performance and safety.

Lara Lacusso

Chief Financial Officer & Company Secretary

Lara Lacusso

Chief Financial Officer & Company Secretary

Lara's 25-year career in financial advisory services, both in Australia and internationally, brings a wealth of knowledge to Prostacare. Her specialization in advising emerging companies on corporate transactions and strategies is vital for our growth. As CFO and Company Secretary, Lara oversees financial management, governance, and commercial matters, ensuring Prostacare's solid financial foundation as we bring our innovative product to market.

Kim Prendergast

Acting Chief Executive Officer

Kim Prendergast

Acting Chief Executive Officer

With more than 20 years in the healthcare industry, Kim is a visionary leader and innovator. Her experience includes a senior directorship at Johnson & Johnson MedTech, where she honed her skills in organizational transformation and rapid growth scenarios. Kim's expertise in navigating the complex healthcare landscape is crucial for Prostacare's mission to revolutionize urological treatments.

Liam Thompson

Operations Manager

Liam Thompson

Operations Manager

Liam oversees Prostacare's operations, bringing a fresh perspective to our research and customer experience initiatives. His background in psychology and data analysis contributes to our strategic approach in product development and market positioning. Liam's role is crucial in translating our innovative technology into practical, user-focused solutions for urological care.

Trusted Advisors

Kea Dent, (KD&A)

Regulatory & Quality Manager

Kea Dent, (KD&A)

Regulatory & Quality Manager

With over 30 years in the medical device sector, Kea's expertise spans manufacturing and regulatory consulting. Her experience in obtaining and maintaining product certifications across global markets is crucial for Prostacare's regulatory compliance. Kea's Regulatory Affairs Certification (RAC) and comprehensive knowledge of medical device lifecycle requirements are invaluable as we navigate the complex regulatory landscape for our new product.

Robert Tucker, MD, PhD

Engineering Consultant

Robert Tucker, MD, PhD

Engineering Consultant

As an Associate Professor of Pathology and Biomedical Engineering, Dr. Tucker's expertise in electrosurgery and thermal ablation is vital to our product's development. His strong engineering and clinical background provides critical oversight in our verification protocols and technical development, ensuring the scientific integrity of our innovative urological treatment.